Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study.

Winthrop KL, Chen L, Fraunfelder FW, Ku JH, Varley CD, Suhler E, Hills WL, Gattey D, Baddley JW, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Herrinton LJ, Fraunfelder FT, Saag KG, Lewis JD, Solomon DH, Curtis JR
Am J Ophthalmol. 2013 155 (1): 183-189.e1

PMID: 22967869 · PMCID: PMC4142597 · DOI:10.1016/j.ajo.2012.06.023

MeSH Terms (21)

Adalimumab Adult Algorithms Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antirheumatic Agents Cohort Studies Databases, Factual Etanercept Female Humans Immunoglobulin G Incidence Infliximab Male Middle Aged Optic Neuritis Receptors, Tumor Necrosis Factor Retrospective Studies Risk Assessment Tumor Necrosis Factor-alpha

Connections (1)

This publication is referenced by other Labnodes entities: